Research programme: growth hormone secretagogue receptor agonists - Bristol-Myers Squibb
Alternative Names: BMS-606056; GHSR agonists - Bristol-Myers SquibbLatest Information Update: 15 Nov 2013
Price :
$50 *
At a glance
- Originator Bristol-Myers Squibb
- Class Heterocyclic bicyclo compounds; Morpholines; Pyridines; Triazoles
- Mechanism of Action Ghrelin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cachexia; Muscular atrophy
Most Recent Events
- 15 Nov 2013 Discontinued - Preclinical for Cachexia in USA (PO)
- 15 Nov 2013 Discontinued - Preclinical for Muscular atrophy in USA (PO)
- 21 Aug 2008 Preclinical trials in Cachexia in USA (PO)